Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mina S Farag"'
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection
Autor:
Willem P. Brouwer, Robert A. de Man, Harry L.A. Janssen, Sylvia M. Brakenhoff, Hannah S.J. Choi, Adam J. Gehring, Grishma Hirode, Milan J Sonneveld, Bettina E. Hansen, Mina S. Farag
Publikováno v:
Journal of Viral Hepatitis, 28(12), 1729-1737. Wiley-Blackwell Publishing Ltd
As pegylated interferon alpha (PEG-IFN-α) is increasingly used in combination regimens of novel drugs, we aimed to characterize ALT flares and their relationship with serum HBsAg and HBV RNA kinetics in a large combined cohort of chronic hepatitis B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa9ffe8998a490aa2bde5597529120e
http://www.scopus.com/inward/record.url?scp=85115875279&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85115875279&partnerID=8YFLogxK
Autor:
Jordan J. Feld, Janett Fischer, Anneke J van Vuuren, Mina S Farag, Bettina E. Hansen, Florian van Bömmel, D Deichsel, Peter Ferenci, Maria Pfefferkorn, Andre Boonstra, Harry L.A. Janssen, Thomas Berg, Margo J. H. van Campenhout
Publikováno v:
Clinical Infectious Diseases, 72(2), 202-211. Oxford University Press
Background Hepatitis B virus RNA (HBV-RNA) is a novel serum biomarker that correlates with transcription of intrahepatic covalently closed circular (cccDNA), which is an important target for pegylated interferon (PEG-IFN) and novel therapies for func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70484904fe3144791c22c6f3ae31640a
https://doi.org/10.1093/cid/ciaa013
https://doi.org/10.1093/cid/ciaa013
Autor:
Gertruda Evaristo, Baharak Khadang, Ronald Kool, Gautier Marcq, Mina S. Farag, Wassim Kassouf, Fadi Brimo
Publikováno v:
Human pathology. 126
While surveillance biopsies play a critical role in management of patients with muscle invasive bladder cancer (MIBC) treated with trimodal therapy (TMT), their assessment is often confounded by pronounced post-treatment changes. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaab4d5b4ea083a028d9328428fe516e
https://pubmed.ncbi.nlm.nih.gov/35490858
https://pubmed.ncbi.nlm.nih.gov/35490858
Autor:
Scott Fung, Bettina E. Hansen, Mina S. Farag, Harry L.A. Janssen, Carla S. Coffin, Mayur Brahmania, Sarah Haylock-Jacobs, Alexander Wong, Philip Wong, Giada Sebastiani, Edward Tam, Alnoor Ramji, Brian Conway, Curtis Cooper, Keith Tsoi, Karen Doucette
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(6)
Tenofovir alafenamide fumarate (TAF) has high plasma stability resulting in fewer renal adverse events compared to tenofovir disoproxil fumarate (TDF) in chronic hepatitis B (CHB) patients. We aimed to study the effectiveness and renal safety of TAF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873509c63d6120a54f8508e7691bac64
https://pubmed.ncbi.nlm.nih.gov/33749086
https://pubmed.ncbi.nlm.nih.gov/33749086
Autor:
Brian Conway, Bettina E. Hansen, Jordan J. Feld, Alexander Wong, Harry L.A. Janssen, Edward Tam, Mina S. Farag, Carla S. Coffin, Curtis Cooper, Seng Liem, Scott Fung, Keith Tsoi, Alnoor Ramji, Karen Doucette
Publikováno v:
Journal of Hepatology. 70:e463-e464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4271d5bc036d3c33a7f74417dd57e3ef
https://doi.org/10.1016/s0618-8278(19)30915-6
https://doi.org/10.1016/s0618-8278(19)30915-6
Autor:
Harry L.A. Janssen, Margo J. H. van Campenhout, Jordan J. Feld, Yilmaz Cakaloglu, Mina S. Farag, Vincent Rijckborst, F. van Boemmel, Fehmi Tabak, Bettina E. Hansen, Peter Ferenci
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27c9bbd18115486778ddbd08014af22
http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L621860513
http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L621860513
